Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report

INTRODUCTION: Systemic B-cell depletion and clinical remission of the systemic effects of cryoglobulins have already been achieved using rituximab in hepatitis C virus-positive immunocompetent patients. Conversely, to the best of our knowledge there are no reports in the literature regarding the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquet, Florian, Combarnous, François, MacGregor, Brigitte, Coppere, Brigitte, Mausservey, Christelle, Ninet, Jacques, Hot, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292813/
https://www.ncbi.nlm.nih.gov/pubmed/22284897
http://dx.doi.org/10.1186/1752-1947-6-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292813/
https://www.ncbi.nlm.nih.gov/pubmed/22284897
http://dx.doi.org/10.1186/1752-1947-6-39

Ejemplares similares